VRPX (Virpax Pharmaceuticals) Beginning Cash Position: $0.02 Mil (As of Dec. 2024)


What is Virpax Pharmaceuticals Beginning Cash Position?

Virpax Pharmaceuticals VRPX Beginning Cash Position is $0.02 Mil as of Dec. 2024.

Virpax Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2024 was $0.02 Mil.

Virpax Pharmaceuticals's quarterly Beginning Cash Position increased from Jun. 2024 ($1.87 Mil) to Sep. 2024 ($1.87 Mil) but then declined from Sep. 2024 ($1.87 Mil) to Dec. 2024 ($0.02 Mil).

Virpax Pharmaceuticals's annual Beginning Cash Position declined from Dec. 2022 ($36.84 Mil) to Dec. 2023 ($19.00 Mil) and declined from Dec. 2023 ($19.00 Mil) to Dec. 2024 ($9.14 Mil).

Virpax Pharmaceuticals Beginning Cash Position Related Terms

Virpax Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Virpax Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virpax Pharmaceuticals Beginning Cash Position Chart

Virpax Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial 0.04 0.05 36.84 19.00 9.14

Virpax Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.15 9.14 1.87 1.87 0.02

Virpax Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.02 Mil mean?
Virpax Pharmaceuticals (VRPX) has a Beginning Cash Position of $0.02 Mil as of Dec. 2024. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Virpax Pharmaceuticals and its competitors.
Is Virpax Pharmaceuticals' Beginning Cash Position too high?
Virpax Pharmaceuticals' current Beginning Cash Position is $0.02 Mil.
How does Virpax Pharmaceuticals' Beginning Cash Position compare to SYGGF and SCPX?
Virpax Pharmaceuticals' Beginning Cash Position of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Virpax Pharmaceuticals and its competitors. Virpax Pharmaceuticals's current Beginning Cash Position is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virpax Pharmaceuticals stock overvalued right now?
Virpax Pharmaceuticals (VRPX) has a current Beginning Cash Position of $0.02 Mil. The current Beginning Cash Position is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Virpax Pharmaceuticals (VRPX), the current Beginning Cash Position is $0.02 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Virpax Pharmaceuticals Business Description

Address 1055 Westlakes Drive, Suite 300, Berwyn, PA, USA, 19312
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.